Nicomni-5 — Nicorandil IP 5 mg, along with approved excipients

Nicomni-5 is a pharmaceutical product manufactured and marketed by EMK Omni Pharma, a trusted pharmaceutical company based in Mysuru, Karnataka. It belongs to the Cardiac Care therapeutic category and is available as a Tablet formulation.

Nicomni-5 by EMK Omni Pharma is a prescription-based Nicorandil Tablets IP 5 mg formulation used for doctor-supervised angina management, chest pain support, and cardiovascular health care. Each uncoated tablet contains Nicorandil IP 5 mg. Nicomni-5 is commonly prescribed by healthcare professionals for patients who require support in managing angina-related chest discomfort, coronary artery disease symptoms, and heart-related vascular conditions. Nicomni-5 Nicorandil 5 mg Tablets by EMK Omni Pharma are designed for physician-guided cardiac care where coronary blood flow support, angina prevention, and heart health management are required. This medicine should be used only as advised by a registered medical practitioner.

Each tablet of Nicomni-5 contains the following active pharmaceutical ingredients:

Active Composition: Nicorandil IP 5 mg, along with approved excipients

Dosage Strength: 5 mg

Medicine Type: Tablet

Pack Size: 10 x 10 Tablets

The formulation is prepared with approved excipients to ensure optimal stability, bioavailability, and therapeutic efficacy. All ingredients comply with Indian Pharmacopoeia (IP) standards where applicable.

Nicomni-5 is classified under the Cardiac Care therapeutic category. This category encompasses medicines that are commonly prescribed by healthcare professionals for conditions related to heart health, angina management, chest pain support, coronary artery disease, and cardiovascular wellness.

Nicomni-5 may be prescribed by doctors for patients who require support in managing angina, chest pain related to heart conditions, coronary artery disease symptoms, and cardiovascular risk factors. It may be used as part of a physician-guided cardiac care plan for individuals who need angina management, coronary circulation support, and long-term heart health monitoring. Nicomni-5 by EMK Omni Pharma is suitable for doctor-supervised treatment where angina support, cardiac care, chest discomfort management, and cardiovascular health support are required. Patients should not self-medicate, change the dosage, stop the medicine, chew the tablet, or combine it with other heart medicines without consulting their doctor.

Nicomni-5 is formulated as a Tablet with a dosage strength of 5 mg. It is available in a pack size of 10 x 10 Tablets.

This product is designed for oral administration and should be taken exactly as prescribed by a registered medical practitioner. Patients should not alter the dosage, crush, chew, or break the tablet unless specifically instructed by their physician.

Important: The dosage and duration of treatment are determined by the prescribing physician based on the patient's individual medical condition, age, weight, and response to treatment.

Proper storage of pharmaceutical products is essential to maintain their quality, potency, and safety. Nicomni-5 should be stored according to the following guidelines:

Nicomni-5 Nicorandil Tablets IP 5 mg should be stored in a dry place at 2°C to 8°C.

General Storage Guidelines:

• Keep the medicine in its original packaging until use
• Do not use the medicine after the expiry date printed on the packaging
• Do not store in the bathroom or near a sink
• Protect from direct sunlight, heat, and humidity
• Keep out of reach of children and pets

Nicomni-5 is a prescription-based pharmaceutical product. It must only be dispensed and used under the guidance of a registered medical practitioner.

Prescription Warning: Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

This medicine is regulated under Indian pharmaceutical laws and is subject to Schedule H / Schedule G drug regulations as applicable. It should not be purchased or used without a valid prescription from a licensed healthcare professional.

For Healthcare Professionals: Nicomni-5 is available through authorised pharmaceutical distribution channels. For product availability, pricing, and distribution enquiries, please contact EMK Omni Pharma directly.

Caution Details: The medicine must be kept out of reach of children.

General Safety Information:

• Do not self-medicate. Always consult a qualified healthcare professional before starting any new medication.
• Inform your doctor about all other medicines, supplements, or herbal products you are currently taking to avoid potential drug interactions.
• If you experience any unexpected side effects or adverse reactions, stop taking the medicine and consult your physician immediately.
• Do not share this medicine with others, even if they have similar symptoms.
• Follow the complete course of treatment as prescribed by your doctor.
• Pregnant or breastfeeding women should consult their physician before using this medicine.
• This medicine is not recommended for use in children unless specifically prescribed by a paediatrician.

EMK Omni Pharma is a trusted pharmaceutical company based in Mysuru, Karnataka, operating as Under the visionary leadership of Kumara Swamy, the company is committed to providing high-quality, physician-guided pharmaceutical products across multiple therapeutic areas.

Our product portfolio includes medicines for Cardiac Care, Cholesterol & Lipid Care, Blood Pressure Management, Nutritional Supplements, Pain Management, and Diabetes Care, all formulated to meet established pharmaceutical quality standards. EMK Omni Pharma works closely with healthcare professionals, pharmacies, hospitals, and distribution partners to ensure that quality medicines reach those who need them — safely, reliably, and responsibly.

Office Address: 2nd Floor, Room No. 01, 102A, Panchamantra Rd, above Kumar Medicals, Kuvempu Nagara, Mysuru, Karnataka 570023

Email: info@emkomnipharma.com

The information provided on this page is intended for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations.

This product information should not be used as a substitute for professional medical advice. Always consult a qualified and registered medical practitioner before starting, stopping, or changing any medication. Self-medication can be harmful and may lead to serious health consequences.

EMK Omni Pharma does not make any therapeutic claims about curing, treating, or preventing any disease without proper clinical evidence and regulatory approval. All products are intended for use only under proper medical supervision.

The product details, composition, and usage guidelines mentioned here are based on the manufacturer's product information and are subject to change. For the most current product information, please refer to the actual product packaging or consult your healthcare provider.